Insider Transactions in Q2 2024 at Exelixis, Inc. (EXEL)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 04
2024
|
Jack L Wyszomierski Director |
SELL
Open market or private sale
|
Direct |
8,287
-2.32%
|
$182,314
$22.0 P/Share
|
|
May 31
2024
|
Mary C Beckerle Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,838
+35.48%
|
-
|
|
May 31
2024
|
Sue Gail Eckhardt Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,838
+35.48%
|
-
|
|
May 31
2024
|
Jack L Wyszomierski Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,838
+5.0%
|
-
|
|
May 31
2024
|
Bob Oliver Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,838
+33.73%
|
-
|
|
May 31
2024
|
Tomas J. Heyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,838
+33.73%
|
-
|
|
May 31
2024
|
Maria C Freire Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,838
+15.95%
|
-
|
|
May 31
2024
|
George Poste Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,838
+7.49%
|
-
|
|
May 31
2024
|
Stelios Papadopoulos Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,838
+1.45%
|
-
|
|
May 31
2024
|
Julie Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,015
+39.31%
|
-
|
|
May 30
2024
|
David Edward Johnson Director |
BUY
Open market or private purchase
|
Indirect |
225,000
+12.85%
|
$4,500,000
$20.76 P/Share
|
|
May 28
2024
|
David Edward Johnson Director |
BUY
Open market or private purchase
|
Indirect |
200,000
+13.33%
|
$4,000,000
$20.32 P/Share
|
|
May 21
2024
|
Julie Smith Director |
SELL
Open market or private sale
|
Direct |
27,280
-83.36%
|
$572,880
$21.12 P/Share
|
|
May 21
2024
|
George Poste Director |
SELL
Open market or private sale
|
Direct |
11,686
-5.18%
|
$233,720
$20.96 P/Share
|
|
May 21
2024
|
George Poste Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,686
+4.93%
|
$222,034
$19.57 P/Share
|
|
May 20
2024
|
Stelios Papadopoulos Director |
SELL
Open market or private sale
|
Direct |
11,437
-0.9%
|
$240,177
$21.0 P/Share
|
|
May 20
2024
|
Stelios Papadopoulos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,686
+0.91%
|
$222,034
$19.57 P/Share
|
|
May 15
2024
|
Christopher J. Senner EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
30,310
-1.36%
|
$606,200
$20.99 P/Share
|
|
May 15
2024
|
Jeffrey Hessekiel EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
25,941
-1.34%
|
$518,820
$20.99 P/Share
|
|
May 15
2024
|
Patrick J. Haley EVP, Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
31,044
-2.07%
|
$620,880
$20.99 P/Share
|
|
May 15
2024
|
Dana Aftab CSO/EVP Disc & Trans Research |
SELL
Payment of exercise price or tax liability
|
Direct |
22,605
-1.41%
|
$452,100
$20.99 P/Share
|
|
May 15
2024
|
Michael Morrissey President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
73,943
-3.63%
|
$1,478,860
$20.99 P/Share
|
|
May 13
2024
|
Jack L Wyszomierski Director |
SELL
Open market or private sale
|
Direct |
10,923
-3.12%
|
$229,383
$21.37 P/Share
|
|
May 13
2024
|
Jack L Wyszomierski Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,686
+3.23%
|
$222,034
$19.57 P/Share
|